19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics become available.
Delayed generic drug uptake may increase spending and worsen medication adherence and patient outcomes.
Recent trends and factors associated with generic uptake were assessed.